These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 16048668)

  • 1. Metabolic syndrome: what is it and what are the implications?
    Shaw DI; Hall WL; Williams CM
    Proc Nutr Soc; 2005 Aug; 64(3):349-57. PubMed ID: 16048668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players.
    Zimmet P; Boyko EJ; Collier GR; de Courten M
    Ann N Y Acad Sci; 1999 Nov; 892():25-44. PubMed ID: 10842650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LIPGENE: an integrated approach to tackling the metabolic syndrome.
    Buttriss J; Nugent A
    Proc Nutr Soc; 2005 Aug; 64(3):345-7. PubMed ID: 16048667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the relationship between exercise and metabolic abnormalities? A review of the metabolic syndrome.
    Carroll S; Dudfield M
    Sports Med; 2004; 34(6):371-418. PubMed ID: 15157122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should the insulin resistance syndrome be treated in the elderly?
    Grant RW; Meigs JB
    Drugs Aging; 2004; 21(3):141-51. PubMed ID: 14979733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of the metabolic syndrome in children.
    Steinberger J
    Curr Opin Lipidol; 2003 Dec; 14(6):555-9. PubMed ID: 14624131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of low-carbohydrate diets on cardiometabolic risk, insulin resistance, and metabolic syndrome.
    O'Neill BJ
    Curr Opin Endocrinol Diabetes Obes; 2020 Oct; 27(5):301-307. PubMed ID: 32773574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metabolic syndrome in overweight and obese schoolchildren in Beijing].
    Wan NJ; Mi J; Wang TY; Duan JL; Li M; Gong CX; Du JB; Zhao XY; Cheng H; Hou DQ; Wang L
    Zhonghua Er Ke Za Zhi; 2007 Jun; 45(6):417-21. PubMed ID: 17880785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of the metabolic syndrome in childhood: an epidemiological overview and mechanistic link to dyslipidemia.
    Kohen-Avramoglu R; Theriault A; Adeli K
    Clin Biochem; 2003 Sep; 36(6):413-20. PubMed ID: 12951167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty acids and the metabolic syndrome.
    Roche HM
    Proc Nutr Soc; 2005 Feb; 64(1):23-9. PubMed ID: 15877919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren.
    Holst-Schumacher I; Nuñez-Rivas H; Monge-Rojas R; Barrantes-Santamaría M
    Food Nutr Bull; 2009 Jun; 30(2):161-70. PubMed ID: 19689095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on the cardiometabolic syndrome.
    Sowers JR
    Clin Cornerstone; 2001; 4(2):17-23. PubMed ID: 11838324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metabolic syndrome].
    Wirth A; Rothenfelde B
    Versicherungsmedizin; 1996 Dec; 48(6):193-9. PubMed ID: 9082643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and factor analysis of obesity, type II diabetes, hypertension, and dyslipidemia (syndrome X) on the Island of Kosrae, Federated States of Micronesia.
    Shmulewitz D; Auerbach SB; Lehner T; Blundell ML; Winick JD; Youngman LD; Skilling V; Heath SC; Ott J; Stoffel M; Breslow JL; Friedman JM
    Hum Hered; 2001; 51(1-2):8-19. PubMed ID: 11096265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone and the metabolic syndrome.
    Johannsson G; Bengtsson BA
    J Endocrinol Invest; 1999; 22(5 Suppl):41-6. PubMed ID: 10442570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of the components of the metabolic syndrome that predispose to diabetes and atherosclerotic CVD.
    Eckel RH
    Proc Nutr Soc; 2007 Feb; 66(1):82-95. PubMed ID: 17343775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study.
    Bonora E; Targher G; Formentini G; Calcaterra F; Lombardi S; Marini F; Zenari L; Saggiani F; Poli M; Perbellini S; Raffaelli A; Gemma L; Santi L; Bonadonna RC; Muggeo M
    Diabet Med; 2004 Jan; 21(1):52-8. PubMed ID: 14706054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Insulin resistance--a physiopathological condition with numerous sequelae: non-insulin-dependent diabetes mellitus (NIDDM), android obesity, essential hypertension, dyslipidemia and atherosclerosis].
    Pedersen O
    Ugeskr Laeger; 1992 May; 154(20):1411-8. PubMed ID: 1631967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metabolic syndrome as a clinical problem.
    Kopelman P
    Nestle Nutr Workshop Ser Clin Perform Programme; 2004; 9():77-92. PubMed ID: 15361680
    [No Abstract]   [Full Text] [Related]  

  • 20. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.